Inflammation: NSAIDs and cardiovascular risk in arthritis

Nat Rev Cardiol. 2017 Feb;14(2):69-70. doi: 10.1038/nrcardio.2016.208. Epub 2017 Jan 5.

Authors

Miguel A González-Gay¹, Carlos González-Juanatey²

Affiliations

¹ University of Cantabria, School of Medicine, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Rheumatology Division, Hospital Universitario Marqués de Valdecilla, Avenida de Valdecilla, s/n, 39008, Santander, Spain.
² Hospital Universitario Lucus Augusti, Cardiology Division, c/ Ulises Romero 1, Lugo 27003, Spain.

PMID: 28054573
DOI: 10.1038/nrcardio.2016.208

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal
Arthritis*
Cardiovascular Diseases*
Celecoxib
Humans
Ibuprofen
Inflammation
Naproxen
Risk Factors

Substances

Anti-Inflammatory Agents, Non-Steroidal
Naproxen
Celecoxib
Ibuprofen